What Ocular Therapeutix, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 8 | 29 |
| Total trades | 10 | 56 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 50,092 | 1,825,260 |
| Disposed | 113,911 | 1,297,946 |
| Net activity | −63,819 | +527,314 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Anderman Todd | Chief Legal Officer | Oct 08 | Sale for tax withholding · S | −11,984 | $7.29 | −$87.4K | 140,484 |
| Heier Jeffrey S. | Chief Scientific Officer | Oct 02 | Sale for tax withholding · S | −10,869 | $7.05 | −$76.6K | 307,457 |
| Kaiser Peter | Chief Development Officer | Oct 02 | Sale for tax withholding · S | −9,990 | $7.05 | −$70.4K | 254,388 |
| Notman Donald | Chief Operating Officer | Aug 31 | Sale for tax withholding · S | −1,099 | $10.24 | −$11.3K | 366,529 |
| Dugel Pravin | See Remarks | Aug 25 | Gift · G | +50,092 | — | — | 744,903 |
| Dugel Pravin | See Remarks | Aug 25 | Gift · G | −50,092 | — | — | 0 |
| Kaiser Peter | Chief Development Officer | Aug 24 | Sale for tax withholding · S | −3,035 | $10.77 | −$32.7K | 264,378 |
| Nayak Sanjay | Chief Strategy Officer | Aug 24 | Sale for tax withholding · S | −1,897 | $10.78 | −$20.4K | 326,898 |
| Heier Jeffrey S. | Chief Scientific Officer | Aug 24 | Sale for tax withholding · S | −3,296 | $10.78 | −$35.5K | 318,326 |
| Dugel Pravin | See Remarks | Aug 24 | Sale for tax withholding · S | −21,649 | $10.77 | −$233K | 2,525,429 |
| Dugel Pravin | See Remarks | Jun 16 | Gift · G | +50,092 | — | — | 50,092 |
| Dugel Pravin | See Remarks | Jun 16 | Gift · G | −50,092 | — | — | 2,547,078 |
| Raines Merilee | Director | Jun 10 | Grant / award · A | +14,000 | — | — | 60,933 |
| Graves Adrienne L | Director | Jun 10 | Grant / award · A | +14,000 | — | — | 64,000 |
| Hong Seung Suh | Director | Jun 10 | Grant / award · A | +14,000 | — | — | 60,933 |
| Williams Leslie J. | Director | Jun 10 | Grant / award · A | +14,000 | — | — | 65,433 |
| Robins Jason Shand | Chief Financial Officer | Jun 10 | Grant / award · A | +15,441 | — | — | 68,097 |
| Warden Charles M | Director | Jun 10 | Grant / award · A | +14,000 | — | — | 100,464 |
| Lindstrom Richard L Md | Director | Jun 10 | Grant / award · A | +14,000 | — | — | 260,933 |
| Waheed Nadia | Chief Medical Officer | Jun 03 | Sale for tax withholding · S | −14,828 | $8.27 | −$123K | 300,079 |
Loading...
